Through
5/7
A round-up of Penn mentions in local, national, and international media.
Penn In the News
Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies.
Penn In the News
Scott Hensley of the Perelman School of Medicine says that a more immunologically naïve population will be the cause of the strong resurgence of influenza and RSV.
Penn In the News
Norbert Pardi of the Perelman School of Medicine explains why mRNA vaccines could remedy some of the challenges faced by previous Ebola vaccinations.
Penn In the News
Katy Milkman of the Wharton School is studying whether different forms of “regret lotteries” might encourage people to get vaccinated.
Penn In the News
Louise Moncla of the School of Veterinary Medicine discusses several of the leading theories for why the bird flu outbreak hasn’t fizzled out.
Penn In the News
Ziyue Gao of the Perelman School of Medicine comments on the innovative promise of the University of Chicago’s work uncovering the Black Death’s effect on human genetics.
Penn In the News
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for their key 2005 advances with synthetic mRNA.
Penn In the News
PIK Professor Ezekiel Emanuel applauds President Biden’s choice of Renee Wegrzyn as new head of ARPA-H, though he hopes Wegrzyn will keep the agency prioritized on health over medicine.
Penn In the News
Michael Mann of the School of Arts & Sciences says that the Inflation Reduction Act isn’t perfect but does return the U.S. to a position of climate action leadership and should encourage midterm turnout for climate-forward legislators.
Penn In the News
Mingyao Li of the Perelman School of Medicine comments on how imaging data can also be a powerful asset for cellular deconvolution.